Eaton Vance Corp:企業の戦略・SWOT・財務分析

◆英語タイトル:Eaton Vance Corp - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5343
◆発行会社(調査会社):MarketLine
◆発行日:2020年3月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,200見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥54,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Eaton Vance Corp – Strategy, SWOT and Corporate Finance Report
Summary

Eaton Vance Corp – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Eaton Vance Corp (EVC) is an investment management and wealth management solutions provider. The company offers investment strategies and wealth management services to institutional and individual clients. It offers services and value added strategies through a range of investment categories. The company’s managing client portfolio established investment discipline and stabilized returns with conscious management of portfolio risks. EVC offers mutual fund, close end funds, and unit investment trusts to individuals. It offers investment strategies, floating rate loans, fixed income investments, and multi-sector bonds to institutional clients. The company offers its services through a network of branch offices in North America, Asia-Pacific, and Europe. EVC headquartered in Boston, Massachusetts, the US.

Scope

- Detailed information on Eaton Vance Corp required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Eaton Vance Corp in the form of a SWOT analysis
- An in-depth view of the business model of Eaton Vance Corp including a breakdown and examination of key business segments
- Intelligence on Eaton Vance Corp’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Eaton Vance Corp, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Eaton Vance Corp and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Eaton Vance Corp as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Eaton Vance Corp’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Eaton Vance Corp: Company Overview
Eaton Vance Corp: Overview and Key Facts
Eaton Vance Corp: Overview
Eaton Vance Corp: Key Facts
Eaton Vance Corp: Key Employees
Eaton Vance Corp: Key Employee Biographies
Eaton Vance Corp: Major Products and Services
Eaton Vance Corp: Company History
Eaton Vance Corp: Management Statement
Eaton Vance Corp: Locations and Subsidiaries
Eaton Vance Corp: Key Competitors
Eaton Vance Corp: Company Analysis
Eaton Vance Corp: Business Description
Eaton Vance Corp: SWOT Analysis
Eaton Vance Corp: SWOT Overview
Eaton Vance Corp: Strengths
Eaton Vance Corp: Weaknesses
Eaton Vance Corp: Opportunities
Eaton Vance Corp: Threats
Eaton Vance Corp: Corporate Financial Deals Activity
Eaton Vance Corp: Financial Deals Overview
Eaton Vance Corp: Targets and Partners
Eaton Vance Corp: Top Deals 2016 – 2020YTD*
Eaton Vance Corp: Advisors
Eaton Vance Corp: Top Financial Advisors
Eaton Vance Corp: Mergers and Acquisitions
Eaton Vance Corp: Corporate Venturing
Eaton Vance Corp: Capital Raising
Eaton Vance Corp: Divestments
Eaton Vance Corp: Recent Developments
Eaton Vance Corp: News and Events Summary
Eaton Vance Corp: Business Expansion
Eaton Vance Corp: Contracts
Eaton Vance Corp: Corporate Governance
Eaton Vance Corp: Financial Deals
Eaton Vance Corp: Financial Performance
Eaton Vance Corp: Regulatory and Legal Events
Eaton Vance Corp: Research & Development
Eaton Vance Corp: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Eaton Vance Corp: Key Facts
Table 2: Eaton Vance Corp: Key Employees
Table 3: Eaton Vance Corp: Company History
Table 4: Eaton Vance Corp: Locations and Subsidiaries
Table 5: Eaton Vance Corp: Key Competitors
Table 6: Eaton Vance Corp: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Eaton Vance Corp: M&A Average Deal Size - Value (US$m)
Table 8: Eaton Vance Corp: Targets and Partners
Table 9: Eaton Vance Corp: Top Deals 2016 - 2020YTD*
Table 10: Eaton Vance Corp: Financial Advisor Ranking by Value (US$m)
Table 11: Eaton Vance Corp: M&A Volume and Value Trend (2016 - YTD*2020)
Table 12: Eaton Vance Corp: M&A Activity by Geography (2016 - YTD*2020)
Table 13: Eaton Vance Corp: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 14: Eaton Vance Corp: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 15: Eaton Vance Corp: Capital Raising by Deal Type (2016 - YTD*2020)
Table 16: Eaton Vance Corp: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 17: Eaton Vance Corp: Divestments by Geography (2016 - YTD*2020)
Table 18: Eaton Vance Corp: News and Events Summary
Table 19: Eaton Vance Corp: Business Expansion
Table 20: Eaton Vance Corp: Contracts
Table 21: Eaton Vance Corp: Corporate Governance
Table 22: Eaton Vance Corp: Financial Deals
Table 23: Eaton Vance Corp: Financial Performance
Table 24: Eaton Vance Corp: Regulatory and Legal Events
Table 25: Eaton Vance Corp: Research & Development
Table 26: Eaton Vance Corp: Strategy and Operations

★海外企業調査レポート[Eaton Vance Corp:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JAND, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary JAND, Inc. (JIN), doing business a warby parker, is a manufacturing company. The company engages in operations of optical manufacturer. JIN product portfolio consists of eyeglasses, sunglasses, and gift cards. The company also manufactures and sale of eyewear for men and women. It also offer …
  • Rajesh Exports Limited:企業の戦略・SWOT・財務情報
    Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report Summary Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • William Hill PLC:企業の戦略・SWOT・財務分析
    William Hill PLC - Strategy, SWOT and Corporate Finance Report Summary William Hill PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Saras SpA (SRS):石油・ガス:M&Aディール及び事業提携情報
    Summary Saras SpA (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industrial …
  • ResApp Health Ltd (RAP):製薬・医療:M&Aディール及び事業提携情報
    Summary ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseas …
  • Machavert Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Machavert Pharmaceuticals LLC (Machavert Pharmaceuticals) is a bio-pharmaceutical company which develops novel non-toxic medicines for the treatment of cancer and autoimmune diseases. Its lead drug candidate MP1000, a nanoparticulate liposomal phospholipid immune-modulating agent exhibits an …
  • AMAG Pharmaceuticals Inc (AMAG)-製薬・医療分野:企業M&A・提携分析
    Summary AMAG Pharmaceuticals Inc (AMAG) is a biopharmaceutical company that develops and commercializes specialty pharmaceutical products. The company focuses on maternal health, anemia management and cancer supportive care. Its major products include Makena (hydroxyprogesterone caproate injection) …
  • L’Oreal SA:戦略・SWOT・企業財務分析
    L'Oreal SA - Strategy, SWOT and Corporate Finance Report Summary L'Oreal SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Xerox Corporation:企業の戦略・SWOT・財務情報
    Xerox Corporation - Strategy, SWOT and Corporate Finance Report Summary Xerox Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Xenikos BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Xenikos BV (Xenikos) is a drug company that develops immunotherapy medicines. The company develops medicines based on the action of conjugated antibodies to patients suffering from serious immune diseases. Its research and development activities includes transplant related rejection, Graft v …
  • Ecopetrol S.A.:企業の戦略・SWOT・財務情報
    Ecopetrol S.A. - Strategy, SWOT and Corporate Finance Report Summary Ecopetrol S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Trellis Bioscience Inc-製薬・医療分野:企業M&A・提携分析
    Summary Trellis Bioscience Inc (Trellis) is a healthcare services provider that offers therapies. The company discovers and develops human antibody therapeutics for the treatment of infectious diseases and cancer indications. It provides technology to defeat the deficiencies of current screening met …
  • National Research Council of Canada:企業のM&A・事業提携・投資動向
    National Research Council of Canada - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Research Council of Canada Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Novo Nordisk AS (NOVO B):企業の財務・戦略的SWOT分析
    Novo Nordisk AS (NOVO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Standardkessel Baumgarte Holding GmbH:企業の戦略的SWOT分析
    Standardkessel Baumgarte Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Sykes Enterprises Inc (SYKE):企業の財務・戦略的SWOT分析
    Sykes Enterprises Inc (SYKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • GS Yuasa Corporation:企業の戦略・SWOT・財務分析
    GS Yuasa Corporation - Strategy, SWOT and Corporate Finance Report Summary GS Yuasa Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Immuron Ltd (IMC):企業の財務・戦略的SWOT分析
    Summary Immuron Ltd (Immuron), formerly Anadis Ltd is a biopharmaceutical company that develops oral immunotherapy therapeutics using polyclonal antibody products for humans. The company develops and produces an orally stable therapeutic for various immune mediated and inflammatory disorders. It pro …
  • Bandai Namco Holdings Inc. (7832):企業の財務・戦略的SWOT分析
    Bandai Namco Holdings Inc. (7832) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Leonardo S.p.A.:企業の戦略・SWOT・財務情報
    Leonardo S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Leonardo S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆